Clinical Trial Update: Indomethacin Decreases Post-ERCP Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 trial completed showing indomethacin reduces post-ERCP pancreatitis. The study suggests prophylactic use of indomethacin may prevent pancreatitis after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Post ERCP Acute Pancreatitis | Phase 3 | Status: COMPLETED